temozolomide has been researched along with Brain Swelling in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is a phase-I study of gefitinib in combination with temozolomide in patients with gliomas." | 9.13 | Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study. ( Chang, S; Cloughesy, T; Dancey, J; Fink, K; Junck, L; Kuhn, J; Prados, MD; Robins, HI; Wen, PY; Yung, WK, 2008) |
| " Food and Drug Administration and EMA-approved xCT inhibitor, sulfasalazine (SAS) in gliomas." | 7.83 | Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. ( Buchfelder, M; Dörfler, A; Engelhorn, T; Eyüpoglu, IY; Fan, Z; Ghoochani, A; Klucken, J; Minakaki, G; Rauh, M; Savaskan, N; Sehm, T, 2016) |
| "Temozolomide (TMZ) is used for treating glioblastoma." | 5.35 | Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells. ( Banik, NL; Das, A; Ray, SK, 2008) |
| "This is a phase-I study of gefitinib in combination with temozolomide in patients with gliomas." | 5.13 | Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study. ( Chang, S; Cloughesy, T; Dancey, J; Fink, K; Junck, L; Kuhn, J; Prados, MD; Robins, HI; Wen, PY; Yung, WK, 2008) |
| " Food and Drug Administration and EMA-approved xCT inhibitor, sulfasalazine (SAS) in gliomas." | 3.83 | Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. ( Buchfelder, M; Dörfler, A; Engelhorn, T; Eyüpoglu, IY; Fan, Z; Ghoochani, A; Klucken, J; Minakaki, G; Rauh, M; Savaskan, N; Sehm, T, 2016) |
| "Cerebral edema was assessed at 4, 12, 22 and 34 weeks post-surgery, together with steroids consumption and patients' psychological status." | 2.90 | A novel lecithin-based delivery form of Boswellic acids as complementary treatment of radiochemotherapy-induced cerebral edema in patients with glioblastoma multiforme: a longitudinal pilot experience. ( Bertuccioli, A; Botta, L; Bruzzone, MG; Cuccarini, V; Di Pierro, F; Fariselli, L; Lamperti, E; Petruzzi, A; Simonetti, G, 2019) |
| "Additionally, there is evidence that treatment-related necrosis occurs more frequently and earlier after temozolomide chemotherapy than after radiotherapy alone." | 2.44 | Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. ( Brandsma, D; Sminia, P; Stalpers, L; Taal, W; van den Bent, MJ, 2008) |
| "Temozolomide (TMZ) is used for treating glioblastoma." | 1.35 | Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells. ( Banik, NL; Das, A; Ray, SK, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, F | 1 |
| Zhang, Y | 1 |
| Wang, N | 1 |
| Song, C | 1 |
| Gao, Y | 1 |
| Diao, X | 1 |
| Zhang, H | 1 |
| Bale, TA | 1 |
| Sait, SF | 1 |
| Benhamida, J | 1 |
| Ptashkin, R | 1 |
| Haque, S | 1 |
| Villafania, L | 1 |
| Sill, M | 1 |
| Sadowska, J | 1 |
| Akhtar, RB | 1 |
| Liechty, B | 1 |
| Juthani, R | 1 |
| Ladanyi, M | 1 |
| Fowkes, M | 1 |
| Karajannis, MA | 1 |
| Rosenblum, MK | 1 |
| Di Pierro, F | 1 |
| Simonetti, G | 1 |
| Petruzzi, A | 1 |
| Bertuccioli, A | 1 |
| Botta, L | 1 |
| Bruzzone, MG | 1 |
| Cuccarini, V | 1 |
| Fariselli, L | 1 |
| Lamperti, E | 1 |
| Li, HL | 1 |
| Cui, XL | 1 |
| Zhang, JN | 1 |
| Lin, S | 1 |
| Pramanik, PP | 1 |
| Parmar, HA | 1 |
| Mammoser, AG | 1 |
| Junck, LR | 1 |
| Kim, MM | 1 |
| Tsien, CI | 1 |
| Lawrence, TS | 1 |
| Cao, Y | 1 |
| Sehm, T | 1 |
| Fan, Z | 1 |
| Ghoochani, A | 1 |
| Rauh, M | 1 |
| Engelhorn, T | 1 |
| Minakaki, G | 1 |
| Dörfler, A | 1 |
| Klucken, J | 1 |
| Buchfelder, M | 1 |
| Eyüpoglu, IY | 1 |
| Savaskan, N | 1 |
| Choi, SH | 1 |
| Kim, JW | 1 |
| Chang, JS | 1 |
| Cho, JH | 1 |
| Kim, SH | 1 |
| Chang, JH | 1 |
| Suh, CO | 1 |
| Matuschek, C | 1 |
| Bölke, E | 1 |
| Nawatny, J | 1 |
| Hoffmann, TK | 1 |
| Peiper, M | 1 |
| Orth, K | 1 |
| Gerber, PA | 1 |
| Rusnak, E | 1 |
| Lammering, G | 1 |
| Budach, W | 1 |
| de Wit, MC | 1 |
| de Bruin, HG | 1 |
| Eijkenboom, W | 1 |
| Sillevis Smitt, PA | 1 |
| van den Bent, MJ | 2 |
| Prados, MD | 1 |
| Yung, WK | 1 |
| Wen, PY | 1 |
| Junck, L | 1 |
| Cloughesy, T | 1 |
| Fink, K | 1 |
| Chang, S | 1 |
| Robins, HI | 1 |
| Dancey, J | 1 |
| Kuhn, J | 1 |
| Das, A | 1 |
| Banik, NL | 1 |
| Ray, SK | 1 |
| Brandsma, D | 1 |
| Stalpers, L | 1 |
| Taal, W | 1 |
| Sminia, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Study Of ZD 1839 And Temozolomide For The Treatment Of Gliomas[NCT00027625] | Phase 1 | 0 participants | Interventional | 2002-01-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for temozolomide and Brain Swelling
| Article | Year |
|---|---|
Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic A | 2011 |
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artifacts; Astrocytoma; Brain Edema; Brain Neoplasms | 2004 |
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Apoptosis; Brain Edema; Brain Neoplasms; Chemother | 2008 |
4 trials available for temozolomide and Brain Swelling
| Article | Year |
|---|---|
A novel lecithin-based delivery form of Boswellic acids as complementary treatment of radiochemotherapy-induced cerebral edema in patients with glioblastoma multiforme: a longitudinal pilot experience.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Alkylating; Brain Edema | 2019 |
Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor.
Topics: Adult; Aged; Brain Edema; Brain Neoplasms; Cisplatin; Dacarbazine; Down-Regulation; Female; Glioma; | 2014 |
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artifacts; Astrocytoma; Brain Edema; Brain Neoplasms | 2004 |
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti | 2008 |
6 other studies available for temozolomide and Brain Swelling
| Article | Year |
|---|---|
Evaluation of the Prognosis of Neuroglioma Based on Dynamic Magnetic Resonance Enhancement.
Topics: Antineoplastic Agents, Alkylating; Brain Edema; Brain Neoplasms; Chemotherapy, Adjuvant; Contrast Me | 2020 |
Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY).
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Edema; Brain Neoplasms; Chemoradiotherapy; Fema | 2021 |
Hypercellularity Components of Glioblastoma Identified by High b-Value Diffusion-Weighted Imaging.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Edema; Brain Neoplasms; Chemoradiotherapy; Dac | 2015 |
Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema.
Topics: Amino Acid Transport System X-AG; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal | 2016 |
Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Edema; Brain Neoplasms; Chemoradiotherapy; Coh | 2017 |
Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells.
Topics: Acetazolamide; Apoptosis; Aquaporin 1; Brain Edema; Brain Neoplasms; Calpain; Carbonic Anhydrases; C | 2008 |